As the world struggles to recover from the outfall of COVID-19, the use of digital health has come under the spotlight.
Healthcare specialists from the UK will be among the European leaders to discuss this new paradigm at the digital HIMSS21 & Health 2.0 European Health Conference, on 7-9 June 2021.
The UK is known for its world-leading experience in genomics. Prof Sharon Peacock, executive director and chair of the COVID-19 Genomics UK (COG-UK) consortium will give her vast knowledge and expertise to the opening keynote session on creating a roadmap out of this coronavirus crisis.
Peacock, who is professor of public health and microbiology at the department of medicine, University of Cambridge, has sought to influence policy in relation to the use of pathogen genomics in britain over the past ten years. She will be one of the experts to take a positive look on how best to move beyond the pandemic, drawing on plans and perspectives of experts from the WHO, the Portuguese Presidency of the EU Council, Israel, the UK, and the US.
Creating an equitable health system
The COVID-19 pandemic has brought the consequences of pre-existing health inequalities into sharp focus. Lord Victor Adebowale, chair of the NHS Confederation will join a keynote session addressing how technology could be used to bridge health inequalities rather than amplify them. Before taking his current role in April 2020, Adebowale was chief executive of the health and social care social enterprise Turning Point. He was awarded a CBE for services to the unemployed and homeless people and turned into a crossbench peer in 2001. Adebowale participate in the very important discussion on how countries can back more equitable health systems as they go beyond COVID-19.
Catching up with non-communicable disease
While COVID-19 caused disruption for health programs globally, the need for continuity of care for patients with chronic conditions did not stop. Duncan Selbie, president of the International Association of National Public Health Institutes and senior advisor to the Saudi Public Health Authority, will be moderating a specialist panel researching the challenges health systems face in catching up with non-communicable diseases . Selbie’s public service career has spanned 41 years and he was the founding chief executive of Public Health England (PHE) from 2012 to 2020. In the session he will discuss how healthcare leaders and clinicians have rapidly coordinated solutions and electronics to reach patients in need and support healing in the pandemic.
Advances in cancer care
Artificial intelligence (AI) has great potential to revolutionise oncology and enable advances in cancer research. Prof Karol Sikora, chief medical officer (CMO) in Rutherford Health, will contribute his expertise to a session exploring the new frontiers of AI and data analytics in oncology. Sikora’s previous roles include CMO in Cancer Partners UK and chairman of the department of cancer medicine at Imperial College School of Medicine. He’ll be part of a panel discussing what’s on the horizon for AI in cancer care and the barriers to promoting large-scale implementations.
A new era of precision wellbeing
Precision health is pushing the frontiers of privacy and interoperability and requiring a new approach to information governance and professional development. Prof Kevin Fenton, regional manager of PHE London and regional director of public health, will participate in a keynote session on entering a new era for data-driven and precision wellbeing . He is one of a board of international experts who will discuss best practices and how to tackle the challenges this new approach brings.